Akzo Nobel N.V.
AKZOF
$68.00
-$0.48-0.71%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -1.02% | -0.16% | -0.98% | -0.73% | 0.42% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -1.02% | -0.16% | -0.98% | -0.73% | 0.42% |
| Cost of Revenue | 0.04% | 1.57% | 0.78% | 0.12% | -0.91% |
| Gross Profit | -2.58% | -2.68% | -3.52% | -1.96% | 2.44% |
| SG&A Expenses | -0.16% | 1.63% | 1.67% | 3.16% | 4.44% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -6,987.81% | 1,965.37% | 107.25% | 109.57% | 110.09% |
| Total Operating Expenses | -4.34% | 5.02% | 2.05% | 2.04% | 1.69% |
| Operating Income | 33.23% | -48.27% | -26.63% | -23.81% | -11.04% |
| Income Before Tax | 25.10% | -59.58% | -21.79% | -15.40% | 6.97% |
| Income Tax Expenses | 40.10% | 6.60% | -10.20% | -23.74% | -16.96% |
| Earnings from Continuing Operations | 18.88% | -85.31% | -26.45% | -10.96% | 21.50% |
| Earnings from Discontinued Operations | -12,470.97% | 63.91% | -- | 119.92% | 99.83% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 25.78% | -2.69% | -9.46% | -16.88% | -21.58% |
| Net Income | 22.78% | -91.99% | -28.57% | -12.19% | 22.85% |
| EBIT | 33.23% | -48.27% | -26.63% | -23.81% | -11.04% |
| EBITDA | 25.69% | -34.74% | -19.14% | -17.23% | -7.27% |
| EPS Basic | 22.51% | -91.97% | -28.66% | -12.27% | 22.77% |
| Normalized Basic EPS | 31.54% | -65.50% | -23.86% | -17.52% | 6.49% |
| EPS Diluted | 22.06% | -92.39% | -28.96% | -12.40% | 22.98% |
| Normalized Diluted EPS | 31.44% | -65.83% | -24.18% | -17.85% | 6.37% |
| Average Basic Shares Outstanding | 0.15% | 0.13% | 0.13% | 0.10% | 0.09% |
| Average Diluted Shares Outstanding | -0.25% | 0.82% | 0.87% | 0.87% | 0.58% |
| Dividend Per Share | 8.36% | 0.45% | 0.45% | -1.01% | -1.01% |
| Payout Ratio | -0.13% | 12.55% | 0.38% | 0.09% | -0.21% |